Quest Diagnostics is rated a Buy driven by demographic tailwinds, improving reimbursement, and disciplined capital returns.

Quest Diagnostics raised its 2026 revenue and EPS guidance after reporting strong Q1 results driven by organic growth, collaborations, and digital innovations. Despite this, Hedgeye shifted its rating ...

Advanced diagnostics in brain health, specifically the AD-Detect Alzheimer's portfolio, saw revenue more than double ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

Add Yahoo as a preferred source to see more of our stories on Google. Mark Brown witnessed the birth of modern diagnostic testing from the back seat of his mother's station wagon. He just doesn't ...

Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer ...

Quest Diagnostics broke ground Wednesday on the site of its new flagship laboratory in Clifton. The 250,000-square-foot facility will be the largest in the Quest network of more than 20 labs across ...

Quest Diagnostics has agreed to acquire some laboratory services assets from New York City-based NewYork-Presbyterian. The assets do not include NewYork-Presbyterian’s hospital-based labs. The deal is ...